United States · FDA National Drug Code directory
Lamotrigine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-361_743955c4-0ece-4619-8e3e-a9e0a51e9491
- Product NDC
- 65862-361
- Form
- TABLET, CHEWABLE
- Composition / generic term
- Lamotrigine
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091104
- Source listing expiry
- 20271231
Source-listed ingredients
- LAMOTRIGINE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, CHEWABLE in 1 BOTTLE (65862-361-01) · 65862-361-01
- 500 TABLET, CHEWABLE in 1 BOTTLE (65862-361-05) · 65862-361-05
- 10 BLISTER PACK in 1 CARTON (65862-361-10) / 10 TABLET, CHEWABLE in 1 BLISTER PACK · 65862-361-10
- 12000 TABLET, CHEWABLE in 1 BOTTLE (65862-361-53) · 65862-361-53
- 1000 TABLET, CHEWABLE in 1 BOTTLE (65862-361-99) · 65862-361-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →